U.S. Biotech Stock News

Zurn Elkay Water Solutions was recently recognized for the sixth consecutive year as one of America’s Most Responsible Companies 2026 by Newsweek and Statista, while also attracting fresh analyst attention following stronger-than-expected third-quarter 2025 results and raised full-year guidance. This combination of sustained ESG recognition and upbeat analyst coverage highlights how Zurn Elkay’s focus on cleaner, safer water is increasingly tied to its financial performance narrative. We’ll...

Carlyle Group (CG) has had an interesting stretch lately, with the stock giving back about 3% in the past day but still sitting on solid gains year to date and over the past month. See our latest analysis for Carlyle Group. That dip takes the latest share price to $58.35, but it comes after a strong run, with a double digit year to date share price return and a powerful multi year total shareholder return. This suggests momentum is cooling slightly rather than reversing. If Carlyle's move has...

In November 2025, Pixalate reported that Magnite ranked among the top sell-side platforms for direct access to the top 100 mobile apps across North America, EMEA, and Asia-Pacific on both the Apple App Store and Google Play. This broad, direct integration with high-traffic mobile apps underscores Magnite’s extensive publisher relationships and reinforces its position in global programmatic advertising supply. Next, we’ll examine how Magnite’s strong direct access to top mobile apps could...

Earlier this month, Twist Bioscience launched research-grade Plasmid DNA Preps offering animal origin-free and transfection-grade options with precise yield controls to support pharmaceutical and biotech customers’ preclinical studies. By targeting stringent quality requirements such as endotoxin-free and animal origin-free DNA, Twist is positioning its platform as a specialized tool provider for nucleic acid therapeutics discovery and development. We’ll now examine how this expansion into...

RealReal (REAL) has been in the spotlight after Chief Accounting Officer Steve Ming Lo sold 62,355 shares, just as investors were still digesting upbeat Q3 results with record growth and improved profitability metrics. See our latest analysis for RealReal. At a share price of $14.34, RealReal’s recent 90 day share price return of 43.4 percent and 1 year total shareholder return of 63.14 percent suggest momentum is still building off the upbeat Q3 narrative, even as insider selling injects a...

Franklin Resources, Inc. has been busy, rolling out its Franklin Small Cap Enhanced ETF while also posting steady assets under management and broad based inflows that suggest its multi year pivot is gaining traction. See our latest analysis for Franklin Resources. All of this product innovation and partnership activity is starting to show up in the numbers, with a roughly 6 percent 1 month share price return and a solid year to date rise suggesting that momentum is rebuilding even as longer...

Recently, analysts upgraded Chord Energy after highlighting its strong free cash flow, cost efficiencies, and balance sheet strength, alongside operational gains from longer drilling laterals and a Williston Basin acquisition. The focus on 4-mile laterals and disciplined capital returns through dividends and aggressive buybacks underscores how operational innovation and capital allocation are shaping Chord’s long-term competitiveness. Next, we’ll examine how this renewed analyst confidence...

Pinnacle West Capital (PNW) has quietly outperformed broader utilities over the past year, and at around $87 a share, investors are starting to ask whether the recent run still leaves upside. See our latest analysis for Pinnacle West Capital. At $87.81, the stock has been edging higher this year, with a 4.15% year to date share price return and a solid 5 year total shareholder return of 39.37%, suggesting steady momentum rather than a speculative spike. If Pinnacle West’s steady climb has you...

JFrog (FROG) has quietly turned into one of the stronger software stories this year, with the stock climbing about 40% over the past 3 months and more than doubling year to date. See our latest analysis for JFrog. That surge has not come out of nowhere, with upbeat execution in its software supply chain platform and growing interest in DevSecOps tools helping drive a 16.7% 1 month share price return, as well as a powerful uptrend in longer term total shareholder returns. If JFrog’s run has...

Hello Group Inc. reported past third-quarter 2025 results showing revenue of CNY 2,650.12 million and net income of CNY 348.89 million, both slightly lower than a year earlier, and guided for fourth-quarter 2025 revenue to decline modestly year over year. The company’s domestic weakness linked to tax and regulatory pressures contrasted with very large overseas growth and the acquisition of European dating app Happn, underscoring a shift toward international expansion to diversify...

Sysco (SYY) shares have drifted lower over the past 3 months, even as revenue and earnings keep grinding higher. That disconnect is prompting investors to revisit what they are actually paying for this cash generating food distributor. See our latest analysis for Sysco. Over the past year, Sysco’s share price return has been slightly negative even as the business posts steady revenue and earnings growth. This suggests sentiment has cooled rather than the underlying cash engine, though its...

Starwood Property Trust (STWD) has quietly outpaced many income names over the past 5 years, and its recent 3 month pullback now has dividend focused investors rechecking the risk reward tradeoff. See our latest analysis for Starwood Property Trust. Zooming out, the share price has eased back to about $18.43 after a 90 day share price return of roughly negative 9 percent. However, a 5 year total shareholder return of just over 50 percent suggests long term income focused holders have still...

Earlier this month, Halozyme Therapeutics, Inc. elected veteran healthcare executive Jim Lang to its Board of Directors, adding deep commercialization, data analytics, and M&A expertise to its governance team. Lang’s track record of scaling EVERSANA through more than twenty acquisitions and leading its merger with Waltz Health may meaningfully influence how Halozyme pursues partnerships, deals, and long-term growth opportunities. We’ll now examine how Halozyme’s recent patent win and Jim...

Construction Partners (ROAD) just delivered a mixed Q3 that still managed to impress the market, with revenue roughly matching forecasts, organic growth falling short, yet full year EBITDA guidance moving higher. See our latest analysis for Construction Partners. The upbeat full year EBITDA outlook appears to be outweighing the organic growth shortfall, with the stock’s recent 7 day share price return of 6.83% helping rebuild momentum after a weaker 90 day patch, while multi year total...

In recent days, Establishment Labs Holdings has drawn increased attention as analysts highlighted its strong growth drivers in the US breast augmentation and reconstruction markets and the supportive backdrop for its medical aesthetics business. This wave of optimism reflects how favorable sector trends and anticipated company-specific catalysts may be reshaping expectations for Establishment Labs Holdings’ long-term trajectory. We’ll now examine how this heightened analyst optimism around...

Voya Financial, in collaboration with SAVVI Financial, recently launched a next-generation retirement income guidance tool that offers workplace plan participants personalized, multi-factor retirement planning at no additional cost, incorporating taxes, health insurance, Social Security, pensions, withdrawal timing and more. By pairing Voya’s workplace savings reach with SAVVI’s optimization engine, the tool brings financial-planning depth once reserved for specialized advisory services...

Earlier this week, the Federal Reserve cut its benchmark interest rate by a quarter-point and softened its labor-market language, signaling a more growth-supportive policy stance that previously helped lift Installed Building Products’ shares. This shift in monetary policy is especially relevant for housing-related companies like Installed Building Products, which are sensitive to borrowing costs and construction activity. We’ll now explore how the Fed’s more growth-focused tone could...

In early December 2025, Garrett Motion Inc. announced that its Board had authorized a share repurchase program of up to US$250,000,000 of common shares, running through 2026 as part of a disciplined capital allocation framework. This buyback plan highlights management’s emphasis on balancing reinvestment in growth areas like electrification with returning capital to shareholders through reduced share count. We’ll now examine how this newly authorized US$250,000,000 buyback could reshape...

A consortium led by Corporación América Airports was previously selected by the Angolan Government to operate, manage, and maintain the new António Agostinho Neto International Airport under a 25-year concession, with an option for a further 15-year extension. This long-term mandate adds a new African hub opportunity to Corporación América Airports’ portfolio, potentially enhancing its geographic diversification and long-range concession pipeline. We’ll now explore how winning a 25-year...

Restaurant Brands International (QSR) has quietly outpaced the broader market over the past 3 months, with the stock up about 11%, as investors reassess its multi brand fast food portfolio. See our latest analysis for Restaurant Brands International. Zooming out, the roughly 11% 3 month share price return fits into a steadier pattern, with an 8.1% year to date share price gain and a 5 year total shareholder return of about 35%. This suggests momentum is gradually building as investors warm to...

Jumia Technologies (NYSE:JMIA) jumped back onto investors radar after reporting a 30% year over year rise in physical goods orders and 35% GMV growth, supported by a standout Black Friday period. See our latest analysis for Jumia Technologies. That growth update has come after a powerful run, with the share price up roughly 214% year to date and a 1 year total shareholder return of about 181%. This suggests momentum is still very much on Jumia’s side as investors reassess its growth and risk...

Cullen/Frost Bankers recently reported Q3 2025 results with earnings per share and revenue slightly ahead of analyst expectations, while Group EVP and General Counsel Rhodes Coolidge E JR sold 700 shares on December 9, 2025, trimming his direct stake. This mix of stronger-than-expected earnings, a 33-year record of dividend increases, and forecasts for weaker profitability offers a nuanced picture of Frost Bank’s outlook. Next, we’ll consider how the insider share sale alongside strong Q3...

Earlier this month, W. R. Berkley Corporation declared a $1.00 per share special cash dividend alongside its regular $0.09 quarterly dividend, both payable on December 29, 2025 to shareholders of record on December 15, 2025, bringing total special cash dividends in 2025 to $1.50 per share. The fresh special dividend, combined with management’s decision to maintain the regular payout and present at Goldman Sachs’ 2025 U.S. Financial Services Conference, underlines an emphasis on returning...

Wondering if JetBlue Airways at around $4.94 is a beaten down bargain or a value trap? You are not alone, and that is exactly what we are going to unpack here. Over the last month the stock has climbed 17.9%, including a 3.1% gain in the past week. However, it is still down sharply at -34.0% year to date and -65.6% over five years, which naturally raises the question of whether sentiment has overshot the fundamentals. Recent headlines have zeroed in on JetBlue's ongoing route adjustments,...